ArticleFrontiers in endocrinology2026
Oestradiol dynamics after polytrauma are linked to injury severity and adverse outcomes.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Women show lower mortality and fewer complications than men after severe polytrauma, but underlying mechanisms remain unclear. In this context, reproductive hormones have gained increasing attention. In particular, oestradiol is controversially discussed: experimental studies suggest protective effects, whereas clinical studies link elevated levels to systemic inflammation and adverse outcomes. Methods: Therefore, in this prospective cohort study, patients with polytrauma(injury severity score ≥16) were enrolled. Hormones (oestradiol, progesterone, testosterone, luteinising hormone [LH], follicle-stimulating hormone [FSH]) were measured on admission and daily on days 1-5. Longitudinal changes were analysed with repeated-measures models. Associations with injury severity and clinical outcomes (organ failure, length of stay, mortality) were assessed using correlation and regression analyses adjusted for relevant confounders. Results: 128 patients, progesterone, testosterone, LH, and FSH declined significantly over time, whereas oestradiol showed an early rise with a peak around the second day followed by a decline. Sex-specific differences were observed for testosterone, LH, and FSH, but not for oestradiol. Elevated oestradiol levels and post-traumatic increases were independently associated with injury severity and adverse outcomes, including organ failure, longer stay and mortality, after adjustment for injury severity. These findings were consistent across different oestradiol metrics (peak, area under the curve, and absolute change). Discussion: be an integral component of the early systemic response to polytrauma and are associated with injury severity and adverse outcomes. These findings challenge the concept of oestradiol as a uniformly protective factor and support its role as a marker of post-traumatic stress and systemic dysregulation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.